These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10159953)

  • 21. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco.
    Bluthenthal RN; Kral AH; Lorvick J; Watters JK
    Med Anthropol; 1997 Dec; 18(1):61-83. PubMed ID: 9458668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV/AIDS behind bars.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV prevention clashes with politics over needle-exchange programs.
    AIDS Alert; 1999 Jun; 14(6):61-3, 65-7. PubMed ID: 11366407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 26. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Needle exchanges do not boost drug use, study says. IDU remains major HIV risk factor.
    AIDS Alert; 2003 Sep; 18(9):112, 114. PubMed ID: 14686305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Petition drive.
    AIDS Policy Law; 1999 Dec; 14(22):16. PubMed ID: 11366655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of drug abuse treatment programs in AIDS prevention and education programs for intravenous drug users: the New Jersey experience.
    Jackson JF; Rotkiewicz LG; Baxter RC
    NIDA Res Monogr; 1990; 93():167-86. PubMed ID: 2300140
    [No Abstract]   [Full Text] [Related]  

  • 33. Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Jun; 38(21):369-74. PubMed ID: 2497335
    [No Abstract]   [Full Text] [Related]  

  • 34. How to run a successful needle exchange program.
    AIDS Alert; 1997 Nov; 12(11):129-31. PubMed ID: 11364772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups.
    Grund JP; Blanken P; Adriaans NF; Kaplan CD; Barendregt C; Meeuwsen M
    J Psychoactive Drugs; 1992; 24(1):41-7. PubMed ID: 1619521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The damage done: a study of injection drug use, injection related abscesses and needle exchange regulation.
    Tomolillo CM; Crothers LJ; Aberson CL
    Subst Use Misuse; 2007; 42(10):1603-11. PubMed ID: 17918030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV transmission in Bangladesh: an analysis of IDU programme coverage.
    Reddy A; Hoque MM; Kelly R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S37-46. PubMed ID: 18207724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National HIV case reporting.
    Fernando MD
    N Engl J Med; 1998 Feb; 338(9):626; author reply 627. PubMed ID: 9480446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.